Zora Biosciences
Mass-spectrometry risk-score blood tests for heart disease and type 2 diabetes, sold with international partners and a Finnish lab
Highlights
- New on EvolcAdded 2026-10-28
About Zora Biosciences
Zora Biosciences Oy is a Finnish diagnostics company with a cardiometabolic focus. It uses mass spectrometry to identify disease markers and develops them into high-throughput clinical diagnostic tests. Its CERT2 test is a ceramide-based cardiovascular risk score for myocardial infarction, cardiovascular death and stroke, and its dSCORE test is a ceramide-based score for the probability of type 2 diabetes onset. A fatty liver disease test is in development.
The tests are commercialised together with international partners or through the company's own reference laboratory in Finland. Partners named on the site include Charité – Universitätsmedizin Berlin, the University of Bergen, the University of Milan and HUS. The site states that Mayo Clinic uses the CERT test.
The company was founded in 2006 and is headquartered in Espoo, Finland. Zora is a partner in the CoroPrevention project, which is funded by the European Commission's Horizon programme.
Product: CERT2 cardiovascular risk score test, dSCORE type 2 diabetes risk score test, and a fatty liver disease test in development, based on mass spectrometry.
Jobs at Zora Biosciences
Leadership
- Reijo Laaksonen · CMO, Co-founderSource: company website
- Reini Hurme · CEO, Co-founderSource: company website
- Riikka Katainen · COOSource: company website
More health & medtech companies
73Health
Remote health examination system that lets doctors clinically examine patients at a distance, for healthcare providersYoung companyNew on EvolcA2 International
Employee wellbeing coaching and a HeiaHeia-based program to help Finnish workplaces improve health and team engagementNew on EvolcAamuHoiva
Private home care and home nursing for households and carers in Hyvinkää, Järvenpää, Mäntsälä and NurmijärviYoung companyNew on EvolcAberia
Child welfare, foster family placement and disability housing services for children, young people and adults in FinlandYoung companyNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Tag Manager
- Google Universal Analytics
- WordPress
- jQuery
- nginx